DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

28.25B

Market cap28.25B

Price-Earnings ratio

35.60

Price-Earnings ratio35.60

Dividend yield

—

Dividend yield—

Average volume

5.10M

Average volume5.10M

High today

$74.35

High today$74.35

Low today

$73.03

Low today$73.03

Open price

$73.57

Open price$73.57

Volume

5.45M

Volume5.45M

52 Week high

$90.00

52 Week high$90.00

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

As of today, DexCom(DXCM) shares are valued at $73.43. The company's market cap stands at 28.25B, with a P/E ratio of 35.60.

As of 2026-02-27, DexCom(DXCM) stock has fluctuated between $73.03 and $74.35. The current price stands at $73.43, placing the stock +0.5% above today's low and -1.2% off the high.

The DexCom(DXCM)'s current trading volume is 5.45M, compared to an average daily volume of 5.1M.

In the last year, DexCom(DXCM) shares hit a 52-week high of $90.00 and a 52-week low of $54.11.

DXCM News

TipRanks 23h

Dexcom Adds Google Executive Rick Osterloh to Board

Dexcom ( (DXCM) ) just unveiled an update. On February 26, 2026, Dexcom’s board expanded to twelve members and appointed Rick Osterloh, Google’s Senior Vice Pr...

Simply Wall St 2d

Assessing DexCom Valuation After Short Term Gains And A 14.5% Undervaluation Narrative

Advertisement Why DexCom Stock Is On Investors’ Radar DexCom (DXCM) has drawn fresh attention after recent trading left the shares near US$73, even as the sto...

Nasdaq 2d

Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars

Key Points Analysts feared the advent of GLP-1 medications would harm DexCom's blood glucose monitoring devices. However, as its turns out, DexCom's devices a...

Analyst ratings

82%

of 33 ratings

Buy

81.8%

Hold

15.2%

Sell

More DXCM News

Simply Wall St 3d

How DexCom’s Strong 2025 Results, Guidance and Buyback Have Changed Its Investment Story

In February 2026, DexCom reported past fourth-quarter 2025 results showing sales of US$1,259.6 million and net income of US$267.3 million, alongside full-year 2...

Simply Wall St 5d

DexCom G7 Rollout And Expansion Shape Growth And Competitive Outlook

DexCom highlighted strong momentum from the successful U.S. rollout of its G7 15 day sensor system in its latest results. Management pointed to encouraging ear...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.